SCHEMBL4669267

SCHEMBL4669267

Cc1[nH]c2c(F)ccc(C)c2c1CCNC(=O)/C=C/c1ccccc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAOB P27338 8/20 0.43
MAOA P21397 1/20 0.41
NFKB1 P19838 1/20 0.41
GAA P10253 1/20 0.39
BACE1 P56817 1/20 0.39
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
ALDH1A1 P00352 2/20 0.37
PKM P14618 1/20 0.37
P4HB P07237 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4755471 1.00 MEN1 (0.46) MEN1KMT2AMAOBMAOANFKB1
SCHEMBL4017359 0.89 MEN1 (0.49) MEN1KMT2AGAALMNASMN1; SMN2
SCHEMBL4017528 0.89 MEN1 (0.49) MEN1KMT2AGAALMNASMN1; SMN2
SCHEMBL13982583 0.87 MEN1 (0.48) MEN1KMT2AGAALMNASMN1; SMN2
SCHEMBL4017822 0.87 GAA (0.55) MEN1KMT2AMAOBGAALMNA
SCHEMBL13982460 0.87 MEN1 (0.47) MEN1KMT2AGAALMNASMN1; SMN2
SCHEMBL4017825 0.85 MMP1 (0.50) MEN1KMT2ABACE1LMNASMN1; SMN2
SCHEMBL4669261 0.85 ALDH1A1 (0.48) MEN1KMT2AGAALMNASMN1; SMN2
SCHEMBL4017363 0.85 MEN1 (0.62) MEN1KMT2AGAALMNASMN1; SMN2
SCHEMBL4667926 0.84 MEN1 (0.45) MEN1KMT2AGAALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008152097-A1 CINNAMIC ACID DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 WO claimed
EP-2003118-A1 Cinnamic acid derivatives as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP claimed
WO-2008152097-A1 CINNAMIC ACID DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 WO disclosed
WO-2008152097-A1 CINNAMIC ACID DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 WO disclosed
EP-2003118-A1 Cinnamic acid derivatives as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP disclosed